The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
Scientists using TwinsUK data and ultra‑precise DNA sequencing have uncovered rare mutations in healthy tissue that could help explain how cancer develops early in life.
Trevor Graham, Professor of Genomics and Evolution and the Director of the Centre for Evolution and Cancer at the Institute of Cancer Research, London, describes efforts to incorporate genome sequencing for cancer detection and treatment.
According to the latest NHS England figures, a record number of women are up to date with their breast screenings. However, many of those invited are still not attending their appointments.
Cancer cells are masters of disguise, evading immune destruction through cunning mechanisms. Groundbreaking research reveals a novel tactic: mitochondrial transfer. Cancer cells cripple immune cells by donating their damaged mitochondria, hindering the immune response and fostering tumour growth.
The UK government is investing £82.6 million in groundbreaking research to harness the power of artificial intelligence (AI) to transform cancer care and accelerate drug discovery.
Lorna Rothery interviewed Dr John Glod from the National Cancer Institute, which is part of the National Institutes of Health, about the main challenges in childhood cancer treatment and the advancements in care.
Tarlatamaba, a new treatment for adult patients with small cell lung cancer (SCLC), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).
The Amplitude Consortium is thrilled to announce its final online workshop, the Amplitude Project Showcase, where the latest advancements in multi-modal imaging for bladder cancer diagnosis and therapy monitoring will be unveiled.
